Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
Pediatric Nephrology
Erschienen in: Pediatric Nephrology 5/2018

15.05.2017 | Educational Review

Muscle wasting in chronic kidney disease

verfasst von: Eduardo A. Oliveira, Wai W. Cheung, Kalodiah G. Toma, Robert H. Mak

Erschienen in: Pediatric Nephrology | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Loss of lean body mass is a relevant component of the cachexia, or protein energy wasting (PEW), syndrome. Reduced muscle mass seems to be the most solid criterion for the presence of cachexia/PEW in patients with chronic kidney disease (CKD), and those with greater muscle mass loss have a higher risk of death. Children with CKD have many risk factors for lean mass and muscle wasting, including poor appetite, inflammation, growth hormone resistance, and metabolic acidosis. Mortality risks in patients with CKD increases as body mass index (BMI) and weight decreases. However, data regarding cachexia/PEW and muscle wasting in children with CKD is scarce due to lack of consensus in diagnostic criteria and an appropriate investigative methodology. Further research is urgently needed to address this important complication in the pediatric CKD setting, which may have fundamental impact on clinical outcomes.
Literatur
1.
Ikizler TA, Cano NJ, Franch H, Fouque D, Himmelfarb J, Kalantar-Zadeh K, Kuhlmann MK, Stenvinkel P, Ter Weee P, Teta D, Wang AY, Wanner C, International Society of Renal N, Metabolism (2013) Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism. Kidney Int 84:1096–1107CrossRefPubMed
2.
Gracia-Iguacel C, Gonzalez-Parra E, Barril-Cuadrado G, Sanchez R, Egido J, Ortiz-Arduan A, Carrero JJ (2014) Defining protein-energy wasting syndrome in chronic kidney disease: prevalence and clinical implications. Nefrologia 34:507–519PubMed
3.
Mak RH, Cheung WW, Zhan JY, Shen Q, Foster BJ (2012) Cachexia and protein-energy wasting in children with chronic kidney disease. Pediatr Nephrol 27:173–181CrossRefPubMed
4.
Mak RH, Ikizler AT, Kovesdy CP, Raj DS, Stenvinkel P, Kalantar-Zadeh K (2011) Wasting in chronic kidney disease. J Cachexia Sarcopenia Muscle 2:9–25CrossRefPubMedPubMedCentral
5.
Ingulli EG, Mak RH (2014) Growth in children with chronic kidney disease: role of nutrition, growth hormone, dialysis, and steroids. Curr Opin Pediatr 26:187–192CrossRefPubMed
6.
Kalantar-Zadeh K, Ikizler TA, Block G, Avram MM, Kopple JD (2003) Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis 42:864–881CrossRefPubMed
7.
Mak RH (2016) Cachexia in children with chronic kidney disease: challenges in diagnosis and treatment. Curr Opin Support Palliat Care.
8.
Mak RH, Cheung W, Cone RD, Marks DL (2006) Leptin and inflammation-associated cachexia in chronic kidney disease. Kidney Int 69:794–797CrossRefPubMed
9.
10.
Mitch WE (2002) Insights into the abnormalities of chronic renal disease attributed to malnutrition. J Am Soc Nephrol 13(Suppl 1):S22–S27PubMed
11.
Abraham AG, Mak RH, Mitsnefes M, White C, Moxey-Mims M, Warady B, Furth SL (2014) Protein energy wasting in children with chronic kidney disease. Pediatr Nephrol 29:1231–1238CrossRefPubMedPubMedCentral
12.
Evans WJ, Morley JE, Argiles J, Bales C, Baracos V, Guttridge D, Jatoi A, Kalantar-Zadeh K, Lochs H, Mantovani G, Marks D, Mitch WE, Muscaritoli M, Najand A, Ponikowski P, Rossi Fanelli F, Schambelan M, Schols A, Schuster M, Thomas D, Wolfe R, Anker SD (2008) Cachexia: a new definition. Clin Nutr 27:793–799CrossRefPubMed
13.
Cheung W, Yu PX, Little BM, Cone RD, Marks DL, Mak RH (2005) Role of leptin and melanocortin signaling in uremia-associated cachexia. J Clin Invest 115:1659–1665CrossRefPubMedPubMedCentral
14.
Muscaritoli M, Anker SD, Argiles J, Aversa Z, Bauer JM, Biolo G, Boirie Y, Bosaeus I, Cederholm T, Costelli P, Fearon KC, Laviano A, Maggio M, Rossi Fanelli F, Schneider SM, Schols A, Sieber CC (2010) Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by special interest groups (SIG) cachexia-anorexia in chronic wasting diseases and nutrition in geriatrics. Clin Nutr 29:154–159CrossRefPubMed
15.
Obi Y, Qader H, Kovesdy CP, Kalantar-Zadeh K (2015) Latest consensus and update on protein-energy wasting in chronic kidney disease. Curr Opin Clin Nutr Metab Care 18:254–262CrossRefPubMedPubMedCentral
16.
Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, Franch H, Guarnieri G, Ikizler TA, Kaysen G, Lindholm B, Massy Z, Mitch W, Pineda E, Stenvinkel P, Trevino-Becerra A, Wanner C (2008) A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 73:391–398CrossRefPubMed
17.
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinkova E, Vandewoude M, Zamboni M, European Working Group on Sarcopenia in Older P (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European Working group on sarcopenia in older people. Age Ageing 39:412–423CrossRefPubMedPubMedCentral
18.
Foley RN, Wang C, Ishani A, Collins AJ, Murray AM (2007) Kidney function and sarcopenia in the United States general population: NHANES III. Am J Nephrol 27:279–286CrossRefPubMed
19.
Kim JK, Choi SR, Choi MJ, Kim SG, Lee YK, Noh JW, Kim HJ, Song YR (2014) Prevalence of and factors associated with sarcopenia in elderly patients with end-stage renal disease. Clin Nutr 33:64–68CrossRefPubMed
20.
Stenvinkel P, Carrero JJ, von Walden F, Ikizler TA, Nader GA (2016) Muscle wasting in end-stage renal disease promulgates premature death: established, emerging and potential novel treatment strategies. Nephrol Dial Transplant 31:1070–1077CrossRefPubMed
21.
Nourbakhsh N, Rhee CM, Kalantar-Zadeh K (2014) Protein-energy wasting and uremic failure to thrive in children with chronic kidney disease: they are not small adults. Pediatr Nephrol 29:2249–2252CrossRefPubMedPubMedCentral
22.
Kovesdy CP, Kopple JD, Kalantar-Zadeh K (2013) Management of protein-energy wasting in non-dialysis-dependent chronic kidney disease: reconciling low protein intake with nutritional therapy. Am J Clin Nutr 97:1163–1177CrossRefPubMedPubMedCentral
23.
Kopple JD, Berg R, Houser H, Steinman TI, Teschan P (1989) Nutritional status of patients with different levels of chronic renal insufficiency. Modification of diet in renal disease (MDRD) study group. Kidney Int Suppl 27:S184–S194PubMed
24.
Kopple JD, Greene T, Chumlea WC, Hollinger D, Maroni BJ, Merrill D, Scherch LK, Schulman G, Wang SR, Zimmer GS (2000) Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study. Kidney Int 57:1688–1703CrossRefPubMed
25.
Fouque D, Pelletier S, Mafra D, Chauveau P (2011) Nutrition and chronic kidney disease. Kidney Int 80:348–357CrossRefPubMed
26.
Lawson JA, Lazarus R, Kelly JJ (2001) Prevalence and prognostic significance of malnutrition in chronic renal insufficiency. J Ren Nutr 11:16–22CrossRefPubMed
27.
Campbell KL, Ash S, Bauer JD, Davies PS (2007) Evaluation of nutrition assessment tools compared with body cell mass for the assessment of malnutrition in chronic kidney disease. J Ren Nutr 17:189–195CrossRefPubMed
28.
Mazairac AH, de Wit GA, Grooteman MP, Penne EL, van der Weerd NC, van den Dorpel MA, Nube MJ, Levesque R, Ter Wee PM, Bots ML, Blankestijn PJ, investigators C (2011) A composite score of protein-energy nutritional status predicts mortality in haemodialysis patients no better than its individual components. Nephrol Dial Transplant 26:1962–1967CrossRefPubMed
29.
Carrero JJ, Chmielewski M, Axelsson J, Snaedal S, Heimburger O, Barany P, Suliman ME, Lindholm B, Stenvinkel P, Qureshi AR (2008) Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients. Clin Nutr 27:557–564CrossRefPubMed
30.
Gracia-Iguacel C, Gonzalez-Parra E, Perez-Gomez MV, Mahillo I, Egido J, Ortiz A, Carrero JJ (2013) Prevalence of protein-energy wasting syndrome and its association with mortality in haemodialysis patients in a centre in Spain. Nefrologia 33:495–505PubMed
31.
32.
Isoyama N, Qureshi AR, Avesani CM, Lindholm B, Barany P, Heimburger O, Cederholm T, Stenvinkel P, Carrero JJ (2014) Comparative associations of muscle mass and muscle strength with mortality in dialysis patients. Clin J Am Soc Nephrol 9:1720–1728CrossRefPubMedPubMedCentral
33.
Kang SH, Park JW, Yoon KW, Do JY (2013) Limb/trunk lean mass ratio as a risk factor for mortality in peritoneal dialysis patients. J Ren Nutr 23:315–323CrossRefPubMed
34.
Lamarca F, Carrero JJ, Rodrigues JC, Bigogno FG, Fetter RL, Avesani CM (2014) Prevalence of sarcopenia in elderly maintenance hemodialysis patients: the impact of different diagnostic criteria. J Nutr Health Aging 18:710–717CrossRefPubMed
35.
Rosenberger J, Kissova V, Majernikova M, Straussova Z, Boldizsar J (2014) Body composition monitor assessing malnutrition in the hemodialysis population independently predicts mortality. J Ren Nutr 24:172–176CrossRefPubMed
36.
Rees L, Jones H (2013) Nutritional management and growth in children with chronic kidney disease. Pediatr Nephrol 28:527–536CrossRefPubMed
37.
Abitbol CL, Zilleruelo G, Montane B, Strauss J (1993) Growth of uremic infants on forced feeding regimens. Pediatr Nephrol 7:173–177CrossRefPubMed
38.
39.
Mitch WE (2005) Cachexia in chronic kidney disease: a link to defective central nervous system control of appetite. J Clin Invest 115:1476–1478CrossRefPubMedPubMedCentral
40.
Bossola M, Tazza L, Luciani G (2009) Mechanisms and treatment of anorexia in end-stage renal disease patients on hemodialysis. J Ren Nutr 19:2–9CrossRefPubMed
41.
Chazot C (2009) Why are chronic kidney disease patients anorexic and what can be done about it? Semin Nephrol 29:15–23CrossRefPubMed
42.
Gunta SS, Mak RH (2013) Ghrelin and leptin pathophysiology in chronic kidney disease. Pediatr Nephrol 28:611–616CrossRefPubMed
43.
Ayestaran FW, Schneider MF, Kaskel FJ, Srivaths PR, Seo-Mayer PW, Moxey-Mims M, Furth SL, Warady BA, Greenbaum LA (2016) Perceived appetite and clinical outcomes in children with chronic kidney disease. Pediatr Nephrol 31:1121–1127CrossRefPubMedPubMedCentral
44.
Foster BJ, Kalkwarf HJ, Shults J, Zemel BS, Wetzsteon RJ, Thayu M, Foerster DL, Leonard MB (2011) Association of chronic kidney disease with muscle deficits in children. J Am Soc Nephrol 22:377–386CrossRefPubMedPubMedCentral
45.
Rashid R, Neill E, Smith W, King D, Beattie TJ, Murphy A, Ramage IJ, Maxwell H, Ahmed SF (2006) Body composition and nutritional intake in children with chronic kidney disease. Pediatr Nephrol 21:1730–1738CrossRefPubMed
46.
Kalantar-Zadeh K, Streja E, Molnar MZ, Lukowsky LR, Krishnan M, Kovesdy CP, Greenland S (2012) Mortality prediction by surrogates of body composition: an examination of the obesity paradox in hemodialysis patients using composite ranking score analysis. Am J Epidemiol 175:793–803CrossRefPubMedPubMedCentral
47.
Lu JL, Molnar MZ, Naseer A, Mikkelsen MK, Kalantar-Zadeh K, Kovesdy CP (2015) Association of age and BMI with kidney function and mortality: a cohort study. Lancet Diabetes Endocrinol 3:704–714CrossRefPubMedPubMedCentral
48.
Lu JL, Kalantar-Zadeh K, Ma JZ, Quarles LD, Kovesdy CP (2014) Association of BMI with outcomes in patients with CKD. J Am Soc Nephrol 25:2088–2096CrossRefPubMedPubMedCentral
49.
Ahmadi SF, Zahmatkesh G, Ahmadi E, Streja E, Rhee CM, Gillen DL, De Nicola L, Minutolo R, Ricardo AC, Kovesdy CP, Kalantar-Zadeh K (2015) Association of Body Mass Index with clinical outcomes in non-dialysis-dependent chronic kidney disease: a systematic review and meta-analysis. Cardiorenal Med 6:37–49CrossRefPubMedPubMedCentral
50.
Wilson FP, Xie D, Anderson AH, Leonard MB, Reese PP, Delafontaine P, Horwitz E, Kallem R, Navaneethan S, Ojo A, Porter AC, Sondheimer JH, Sweeney HL, Townsend RR, Feldman HI, Investigators CS (2014) Urinary creatinine excretion, bioelectrical impedance analysis, and clinical outcomes in patients with CKD: the CRIC study. Clin J Am Soc Nephrol 9:2095–2103CrossRefPubMedPubMedCentral
51.
Pereira RA, Cordeiro AC, Avesani CM, Carrero JJ, Lindholm B, Amparo FC, Amodeo C, Cuppari L, Kamimura MA (2015) Sarcopenia in chronic kidney disease on conservative therapy: prevalence and association with mortality. Nephrol Dial Transplant 30:1718–1725CrossRefPubMed
52.
Schiffrin EL, Lipman ML, Mann JF (2007) Chronic kidney disease: effects on the cardiovascular system. Circulation 116:85–97CrossRefPubMed
53.
Cheung WW, Paik KH, Mak RH (2010) Inflammation and cachexia in chronic kidney disease. Pediatr Nephrol 25:711–724CrossRefPubMed
54.
Mak RH, Cheung W (2007) Cachexia in chronic kidney disease: role of inflammation and neuropeptide signaling. Curr Opin Nephrol Hypertens 16:27–31CrossRefPubMed
55.
Pecoits-Filho R, Sylvestre LC, Stenvinkel P (2005) Chronic kidney disease and inflammation in pediatric patients: from bench to playground. Pediatr Nephrol 20:714–720CrossRefPubMed
56.
Zyga S, Christopoulou G, Malliarou M (2011) Malnutrition-inflammation-atherosclerosis syndrome in patients with end-stage renal disease. J Ren Care 37:12–15CrossRefPubMed
57.
Lowrie EG, Lew NL (1990) Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15:458–482CrossRefPubMed
58.
Wong CS, Hingorani S, Gillen DL, Sherrard DJ, Watkins SL, Brandt JR, Ball A, Stehman-Breen CO (2002) Hypoalbuminemia and risk of death in pediatric patients with end-stage renal disease. Kidney Int 61:630–637CrossRefPubMed
59.
Jones CH, Wells L, Stoves J, Farquhar F, Woodrow G (2002) Can a reduction in extracellular fluid volume result in increased serum albumin in peritoneal dialysis patients? Am J Kidney Dis 39:872–875CrossRefPubMed
60.
Kalantar-Zadeh K, Kopple JD (2001) Relative contributions of nutrition and inflammation to clinical outcome in dialysis patients. Am J Kidney Dis 38:1343–1350CrossRefPubMed
61.
Warady BA, Abraham AG, Schwartz GJ, Wong CS, Munoz A, Betoko A, Mitsnefes M, Kaskel F, Greenbaum LA, Mak RH, Flynn J, Moxey-Mims MM, Furth S (2015) Predictors of rapid progression of glomerular and Nonglomerular kidney disease in children and adolescents: the chronic kidney disease in children (CKiD) cohort. Am J Kidney Dis 65:878–888CrossRefPubMedPubMedCentral
62.
Ku E, Glidden DV, Hsu CY, Portale AA, Grimes B, Johansen KL (2016) Association of Body Mass Index with patient-centered outcomes in children with ESRD. J Am Soc Nephrol 27:551–558CrossRefPubMed
63.
Bonthuis M, van Stralen KJ, Verrina E, Groothoff JW, Alonso Melgar A, Edefonti A, Fischbach M, Mendes P, Molchanova EA, Paripovic D, Peco-Antic A, Printza N, Rees L, Rubik J, Stefanidis CJ, Sinha MD, Zagozdzon I, Jager KJ, Schaefer F (2013) Underweight, overweight and obesity in paediatric dialysis and renal transplant patients. Nephrol Dial transplant 28 Suppl 4:iv195-iv204.
64.
Foster BJ, McCauley L, Mak RH (2012) Nutrition in infants and very young children with chronic kidney disease. Pediatr Nephrol 27:1427–1439CrossRefPubMed
65.
66.
Bismuth K, Relaix F (2010) Genetic regulation of skeletal muscle development. Exp Cell Res 316:3081–3086CrossRefPubMed
67.
Mavalli MD, DiGirolamo DJ, Fan Y, Riddle RC, Campbell KS, van Groen T, Frank SJ, Sperling MA, Esser KA, Bamman MM, Clemens TL (2010) Distinct growth hormone receptor signaling modes regulate skeletal muscle development and insulin sensitivity in mice. J Clin Invest 120:4007–4020CrossRefPubMedPubMedCentral
68.
Otto A, Patel K (2010) Signalling and the control of skeletal muscle size. Exp Cell Res 316:3059–3066CrossRefPubMed
69.
Avin KG, Moorthi RN (2015) Bone is not alone: the effects of skeletal muscle dysfunction in chronic kidney disease. Curr Osteoporos Rep 13:173–179CrossRefPubMedPubMedCentral
70.
Tsampalieros A, Kalkwarf HJ, Wetzsteon RJ, Shults J, Zemel BS, Foster BJ, Foerster DL, Leonard MB (2013) Changes in bone structure and the muscle-bone unit in children with chronic kidney disease. Kidney Int 83:495–502CrossRefPubMed
71.
Wetzsteon RJ, Kalkwarf HJ, Shults J, Zemel BS, Foster BJ, Griffin L, Strife CF, Foerster DL, Jean-Pierre DK, Leonard MB (2011) Volumetric bone mineral density and bone structure in childhood chronic kidney disease. J Bone Miner Res 26:2235–2244CrossRefPubMedPubMedCentral
72.
Castaneda C, Gordon PL, Parker RC, Uhlin KL, Roubenoff R, Levey AS (2004) Resistance training to reduce the malnutrition-inflammation complex syndrome of chronic kidney disease. Am J Kidney Dis 43:607–616CrossRefPubMed
73.
Heiwe S, Jacobson SH (2011) Exercise training for adults with chronic kidney disease. Cochrane database Syst rev:CD003236.
74.
Clapp EL, Bevington A, Smith AC (2012) Exercise for children with chronic kidney disease and end-stage renal disease. Pediatr Nephrol 27:165–172CrossRefPubMed
75.
Lau KK, Obeid J, Breithaupt P, Belostotsky V, Arora S, Nguyen T, Timmons BW (2015) Effects of acute exercise on markers of inflammation in pediatric chronic kidney disease: a pilot study. Pediatr Nephrol 30:615–621CrossRefPubMed
76.
Clark SL, Denburg MR, Furth SL (2016) Physical activity and screen time in adolescents in the chronic kidney disease in children (CKiD) cohort. Pediatr Nephrol 31:801–808CrossRefPubMed
77.
Paglialonga F, Lopopolo A, Scarfia RV, Consolo S, Galli MA, Salera S, Grassi MR, Brivio A, Edefonti A (2014) Intradialytic cycling in children and young adults on chronic hemodialysis. Pediatr Nephrol 29:431–438CrossRefPubMed
78.
Cheung WW, Mak RH (2010) Ghrelin in chronic kidney disease. Int J Pept 2010
79.
Mak RH, Cheung WW, Gertler A (2014) Exploiting the therapeutic potential of leptin signaling in cachexia. Curr Opin Support Palliat Care 8:352–357CrossRefPubMed
Metadaten
Titel
Muscle wasting in chronic kidney disease
verfasst von
Eduardo A. Oliveira
Wai W. Cheung
Kalodiah G. Toma
Robert H. Mak
Publikationsdatum
15.05.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 5/2018
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-017-3684-6

Weitere Artikel der Ausgabe 5/2018

Pediatric Nephrology 5/2018 Zur Ausgabe

Editorial Commentary

Unacylated ghrelin and obestatin in pediatric CKD: are they important in protein energy wasting?

Clinical Quiz

Neonatal stroke and haematuria: Answers

Clinical Quiz

A child with macroscopic crystalluria: Questions

Original Article

Autologous arteriovenous fistulas for hemodialysis using microsurgery techniques in children weighing less than 20 kg

Original Article

Stereological study of developing glomerular forms during human fetal kidney development

Clinical Quiz

A child with macroscopic crystalluria: Answers

Neu im Fachgebiet Pädiatrie

23.04.2024 | Typ-1-Diabetes | Nachrichten

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

22.04.2024 | Fehlsichtigkeit | Nachrichten

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

18.04.2024 | Spinale Muskelatrophien | Nachrichten

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 | Pädiatrische Notfallmedizin | Nachrichten

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind
weitere anzeigen

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen